[go: up one dir, main page]

AR053477A1 - Cartamo con acido gamma - linolenico elevado - Google Patents

Cartamo con acido gamma - linolenico elevado

Info

Publication number
AR053477A1
AR053477A1 ARP060102090A ARP060102090A AR053477A1 AR 053477 A1 AR053477 A1 AR 053477A1 AR P060102090 A ARP060102090 A AR P060102090A AR P060102090 A ARP060102090 A AR P060102090A AR 053477 A1 AR053477 A1 AR 053477A1
Authority
AR
Argentina
Prior art keywords
seeds
safflower
gla
sequences
linolenic
Prior art date
Application number
ARP060102090A
Other languages
English (en)
Original Assignee
Arcadia Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcadia Biosciences Inc filed Critical Arcadia Biosciences Inc
Publication of AR053477A1 publication Critical patent/AR053477A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

La presente se refiere a composiciones y métodos para preparar ácido gamma-linoleico (GLA) en plantas de cártamo, particularmente de semillas de cártamo. Las secuencias de ácidos nucleicos y construcciones que codifican una o más secuencias de desaturasas de ácidos grasos se utilizan para generar plantas de cártamo transgénicas que contienen y expresan una o más de estas secuencias y producen altos niveles de GLA en semillas de cártamo. Se proporcionan plantas de cártamo transgénicas y semillas que producen altos niveles de GLA. Se proporcionan además aceites producidos de semillas de la presente. La presente también se refiere a métodos de tratamiento de una variedad de enfermedades incluyendo trastornos del sistema nervioso, afecciones inflamatorias, cáncer y trastornos cardiovasculares utilizando los aceites de la presente.
ARP060102090A 2005-05-23 2006-05-22 Cartamo con acido gamma - linolenico elevado AR053477A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68413405P 2005-05-23 2005-05-23
US73598405P 2005-11-10 2005-11-10

Publications (1)

Publication Number Publication Date
AR053477A1 true AR053477A1 (es) 2007-05-09

Family

ID=37452775

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102090A AR053477A1 (es) 2005-05-23 2006-05-22 Cartamo con acido gamma - linolenico elevado

Country Status (12)

Country Link
US (2) US7893321B2 (es)
EP (1) EP1885862B1 (es)
JP (1) JP5033122B2 (es)
CN (1) CN101321872B (es)
AR (1) AR053477A1 (es)
AU (1) AU2006249983B2 (es)
BR (1) BRPI0611480B1 (es)
CA (1) CA2609367C (es)
CL (1) CL2007003413A1 (es)
ES (1) ES2550623T3 (es)
NZ (1) NZ563676A (es)
WO (1) WO2006127789A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073787A2 (en) * 2004-12-20 2006-07-13 Basf Plant Science Gmbh Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use
JP2009543561A (ja) 2006-07-14 2009-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション イネの脂肪酸組成の改変
EP2271223A2 (de) * 2008-04-25 2011-01-12 BASF Plant Science GmbH Pflanzensamenöl
EP2304032A1 (en) * 2008-08-01 2011-04-06 E. I. du Pont de Nemours and Company 6 desaturases and their use in making polyunsaturated fatty acids
HK1207938A1 (en) 2012-04-25 2016-02-19 Commonwealth Scientific And Industrial Research Organisation High oleic acid oils
HUE033766T2 (en) 2012-06-15 2018-01-29 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
EP3080250A1 (en) 2013-12-10 2016-10-19 The University of York Desaturase nucleic acids and polypeptides
CA3241340A1 (en) 2013-12-18 2015-06-25 Grains Research And Development Corporation Lipid comprising long chain polyunsaturated fatty acids
EP3160482A4 (en) 2014-06-27 2018-02-14 Commonwealth Scientific and Industrial Research Organisation Lipid comprising docosapentaenoic acid
SG11202107010QA (en) * 2018-12-28 2021-07-29 Nippon Suisan Kaisha Ltd DIHOMO-γ-LINOLENIC ACID-CONTAINING MICROBIAL OIL WITH REDUCED ARACHIDONIC ACID CONTENT

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4743548A (en) 1984-09-25 1988-05-10 Calgene, Inc. Plant cell microinjection technique
US4943674A (en) 1987-05-26 1990-07-24 Calgene, Inc. Fruit specific transcriptional factors
US5420034A (en) 1986-07-31 1995-05-30 Calgene, Inc. Seed-specific transcriptional regulation
US5068193A (en) 1985-11-06 1991-11-26 Calgene, Inc. Novel method and compositions for introducing alien DNA in vivo
US4795855A (en) 1985-11-14 1989-01-03 Joanne Fillatti Transformation and foreign gene expression with woody species
US5188958A (en) 1986-05-29 1993-02-23 Calgene, Inc. Transformation and foreign gene expression in brassica species
US5565347A (en) 1986-06-10 1996-10-15 Calgene, Inc. Transformation and foreign gene expression with plant species
DE3856589D1 (de) 1987-10-20 2006-04-06 Bayer Bioscience Nv 5'-flankierende Region eines Genes von Arabidopsis, das für einen 2S Albumin-Prekursor kodiert
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
US5565346A (en) 1988-07-27 1996-10-15 Calgene, Inc. Transformation and regeneration system for legumes
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US5175095A (en) 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
PH31293A (en) 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
US6355861B1 (en) 1991-10-10 2002-03-12 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a Δ6-desaturase
US5614393A (en) * 1991-10-10 1997-03-25 Rhone-Poulenc Agrochimie Production of γ-linolenic acid by a Δ6-desaturase
EP0633940B1 (en) 1992-04-02 2002-12-04 SemBioSys Genetics Inc. Oil-body protein cis-elements as regulatory signals
US5539092A (en) 1992-10-02 1996-07-23 Arch Development Corporation Cyanobacterial and plant acetyl-CoA carboxylase
DE69424861T2 (de) 1993-02-26 2000-12-28 Calgene Llc., Davis Geminivirus-basiertes-genexpressionsystem
US5968809A (en) 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
SK139999A3 (en) * 1997-04-11 2000-05-16 Calgene Llc A nucleic acids construct, isolated nucleotide sequence, recombinant plant cell, method of biosynthesis of polyunsaturated long chain fatty acids, pharmaceutical, food and cosmetic preparation and use thereof
US6075183A (en) 1997-04-11 2000-06-13 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US6432684B1 (en) 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
US5972664A (en) 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6051754A (en) 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
IL132393A0 (en) * 1997-04-15 2001-03-19 Commw Scient Ind Res Org Plant fatty acid epoxygenase genes and uses therefor
JP2001518305A (ja) 1997-09-30 2001-10-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 植物種子におけるタンパク質製造
US6653530B1 (en) * 1998-02-13 2003-11-25 Calgene Llc Methods for producing carotenoid compounds, tocopherol compounds, and specialty oils in plant seeds
US6492108B1 (en) 1998-03-26 2002-12-10 Incyte Genomics, Inc. Delta-6 desaturase homologs
EP1895009A1 (en) 1998-06-12 2008-03-05 Calgene LLC Polyunsaturated fatty acids in plants
US6677145B2 (en) * 1998-09-02 2004-01-13 Abbott Laboratories Elongase genes and uses thereof
US6403349B1 (en) * 1998-09-02 2002-06-11 Abbott Laboratories Elongase gene and uses thereof
US6342657B1 (en) 1999-05-06 2002-01-29 Rhone-Poulenc Agro Seed specific promoters
PL357415A1 (en) * 1999-06-07 2004-07-26 Basf Plant Science Gmbh Delta6-acetylenase and delta6-desaturase from ceratodon purpureus
US6815579B1 (en) * 1999-07-22 2004-11-09 The University Of British Columbia Plant long chain fatty acid biosynthetic enzyme
US6777591B1 (en) 1999-08-27 2004-08-17 Sembiosys Genetics Inc. Legume-like storage protein promoter isolated from flax and methods of expressing proteins in plant seeds using the promoter
US7544859B2 (en) * 2000-02-09 2009-06-09 Basf Aktiengesellschaft Elongase gene and method for producing multiple-unsaturated fatty acids
DE10102337A1 (de) * 2001-01-19 2002-07-25 Basf Plant Science Gmbh Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren, neue Biosynthesegene sowie neue pflanzliche Expressionskonstrukte
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
BR0205508A (pt) 2001-01-25 2005-05-03 Abbott Lab Genes para dessaturase e usos dos mesmos
PT1440151E (pt) * 2001-09-05 2008-03-17 Monsanto Technology Llc Promotor 7s alfa específico da semente para expressar genes em plantas
JP4864701B2 (ja) 2003-06-17 2012-02-01 セムバイオシス ジェネティクス インコーポレイテッド 植物におけるインスリンの製造方法
MX347962B (es) * 2003-08-01 2017-05-19 Basf Plant Science Gmbh * Metodo para la produccion de acidos grasos poli-insaturados en organismos transgenicos.

Also Published As

Publication number Publication date
WO2006127789A3 (en) 2007-11-29
CL2007003413A1 (es) 2008-07-25
WO2006127789A9 (en) 2012-03-01
US7893321B2 (en) 2011-02-22
US20110129428A1 (en) 2011-06-02
EP1885862A4 (en) 2009-02-25
BRPI0611480B1 (pt) 2016-06-07
NZ563676A (en) 2011-01-28
ES2550623T3 (es) 2015-11-11
WO2006127789A2 (en) 2006-11-30
JP2008545411A (ja) 2008-12-18
CN101321872A (zh) 2008-12-10
CA2609367C (en) 2014-08-19
AU2006249983B2 (en) 2011-03-17
JP5033122B2 (ja) 2012-09-26
CA2609367A1 (en) 2006-11-30
BRPI0611480A2 (pt) 2010-09-14
EP1885862A2 (en) 2008-02-13
HK1120823A1 (en) 2009-04-09
EP1885862B1 (en) 2015-07-29
AU2006249983A1 (en) 2006-11-30
CN101321872B (zh) 2012-09-05
US8192964B2 (en) 2012-06-05
US20070067870A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
CL2025001987A1 (es) Método para producir una planta modificada.
AR091482A1 (es) Celulas modificadas geneticamente y metodos par su obtencion
CL2017000465A1 (es) Generación de plantas haploides
AR086995A1 (es) Metodos y composiciones para producir plantas con esterilidad masculina
AR103446A1 (es) Método para modificar con precisión una planta a través de la expresión transitoria de genes
AR075356A1 (es) Promotores inducibles por patogenos y su uso en el mejoramiento de la resistencia a las enfermedades en plantas
BR112015023378A2 (pt) métodos de modular sementes de plantas e conteúdo nectário
AR101331A1 (es) Composiciones y métodos para incrementar el crecimiento y rendimiento de las plantas
AR059650A1 (es) Plantas que presentan aumento en el rendimiento y metodo para lograrlo
AR105760A1 (es) Métodos y constructos para la modificación específica de ácidos nucleicos en plantas
AR053477A1 (es) Cartamo con acido gamma - linolenico elevado
MX2017014245A (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas.
CR5812A (es) Induccion de esterilidad masculina en plantas mediante expresion de elevados niveles de adivina
AR104572A1 (es) Gen de resistencia al tizón tardío de solanum americanum y métodos de uso
AR053279A1 (es) Regulacion post-transcripcional de la expresion genica
CL2017002320A1 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
AR069787A1 (es) Proteinas del metabolismo de los lipidos, combinaciones de proteinas del metabolismo de los lipidos y sus usos
AR114072A1 (es) Plantas con genes dhs modificados
AR075126A1 (es) Metodo para el mejor uso del potencial de produccion de plantas transgenicas
CL2017003012A1 (es) Moléculas de ácidos nucleicos de spt5 para controlar plagas de insectos.
CL2015000016A1 (es) Plantas brassica con composición de aceite de semilla modificada
EA201991714A1 (ru) Регуляторные элементы растений и их использование
CL2017001523A1 (es) Supresion parental rnai del gen hunchback para el control de plagas de coleopteros
AR110616A1 (es) Composiciones y métodos para generar un haploide de una planta objeto
CL2022000468A1 (es) Línea nubj1207 de brassica juncea

Legal Events

Date Code Title Description
FG Grant, registration